- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
China-based ultrasound firm picks U.S. Medical as main distributor
SIUI moves into U.S. market and toward its own designs Medical equipment distributor U.S. Medical has formed a partnership with Shantou Institute of Ultrasonic Instruments to sell SIUI's ultrasound systems in the U.S. The two companies anticipate the
SIUI moves into U.S. market and toward its own designs
Medical equipment distributor U.S. Medical has formed a partnership with Shantou Institute of Ultrasonic Instruments to sell SIUI's ultrasound systems in the U.S. The two companies anticipate the deal will evolve into an exclusive relationship.
"SIUI is the largest ultrasound company in China. Their prices are generally much lower than other systems," said Craig Borman, U.S. Medical's vice president for medical diagnostics.
The China-based company has been selling ultrasound scanners for many years in Asia, Europe, and South America, according to SIUI's marketing director, James Ma, who said FDA clearance for five models has opened up the U.S. market.
"Our products are relatively inexpensive but have high value," Ma said.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
